FIELD: medicine.
SUBSTANCE: group of inventions refers to a transdermal device comprising porous microparticles that are capable of containing nicotine as an active ingredient. The device is used as a medicine, in particular, in case of smoking refusal. The invention also relates to a method for manufacture of a transdermal device comprising porous microparticles carrying the active ingredient.
EFFECT: device exhibits improved cohesive properties, in particular reduces the risk of leakage, and reduces the amount of matrix remaining on the skin after patch removal.
17 cl, 4 dwg, 7 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF NICOTINE ADDICTION IN PATIENTS WITH PULMONARY TUBERCULOSIS | 2022 |
|
RU2801915C1 |
| TRANSDERMAL MEMANTINE DELIVERY SYSTEMS | 2017 |
|
RU2764764C2 |
| TRANSDERMAL DONEPEZIL DELIVERY SYSTEM | 2017 |
|
RU2779471C2 |
| COMPOSITION FOR TEETH WHITENING, CONTAINING CROSS-LINKING POLYMER-PEROXYDES | 2005 |
|
RU2362542C2 |
| CURING MULTICOMPONENT ACRYLIC COMPOSITION | 2014 |
|
RU2712216C2 |
| TRANSDERMAL SYSTEM FOR VARENICLINE | 2006 |
|
RU2388461C2 |
| PERCUTANEOUS DELIVERY SYSTEM, USING MICROPOROUS MEMBRANE CONTAINING PORES FILLED WITH SOLVENT | 2018 |
|
RU2789194C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL INJECTION OF GUANFACINE, CONTAINING SILICONE POLYMER | 2018 |
|
RU2792822C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM | 2020 |
|
RU2791107C1 |
| COMPOSITION FOR DRUG DELIVERY CONTAINING SILYL POLYMERS | 2016 |
|
RU2737707C2 |
